Partner Mike Okaty was quoted in Pacific Coast Business Times discussing the difference between a typical IPO and a SPAC IPO in an article titled, “Santa Barbara County cannabis company to go public in $567M merger.”
Okaty told Pacific Coast Business Times, “You generally gain quicker access to the public markets at generally higher valuations and without some of the restraints that you have in a typical IPO.” He added, “If you do an IPO, you have your IPO day and if it’s a down day in the market, the price can go down, versus a SPAC which goes public when it wants, does the transaction to acquire the operating business more or less when it wants.”
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”